CEBPD and cardiovascular disorder: These studies indicate that upregulation of CEBPD in cardiomyocytes, macrophages, VSMCs, and vascular endothelial cells is involved in the progression of cardiovascular diseases via different mechanisms, highlighting new avenues for the development of novel therapies targeting CEBPD to treat or alleviate cardiovascular diseases (Fig. 3).